Causes of death in AIDS patients

April 28, 2010, University of Bristol

(PhysOrg.com) -- New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.

The study, by researchers from the University of Bristol and a large group of international collaborators, examined data from the Antiretroviral Therapy Cohort Collaboration (ART-CC) which involved nearly 40,000 patients who started ART between 1996 and 2006 in Europe and North America.

Of the 1,876 deaths that occurred in that time, a definitive cause of death could be assigned to 85% of cases. Overall, almost 50% of patients died from which remains the most common cause of death.

However, although during the first year of treatment with ART the majority of deaths were AIDS-related, because deaths from AIDS decline with time for patients on ART, non-AIDS-related deaths exceeded AIDS deaths after patients had been taking ART for approximately four years.

Lifestyle-related causes of death such as suicide, drug overdose and liver disease (mainly due to hepatitis) were the most frequent causes (15%) of non-AIDS deaths, and the most common non-AIDS cancer reported was lung cancer (4% of all deaths and 37% of all non-AIDS cancer deaths) which was probably associated with smoking.

Increases in rates of deaths from causes associated with aging, such as other cancers (12%) and cardiovascular disease (6.5%), imply that the process of aging will become a dominant factor in mortality in the next decade.

Dr Margaret May, corresponding author on the paper published online in Clinical said, "We also found a strong inverse association of rates of AIDS death with CD4 counts - a measure of - at the time of starting ART, which supports arguments for earlier initiation of ART.”

After the year 2000, the team found lower rates of AIDS deaths that may be the result of newer ART regimens having better potency and tolerability.

Interventions to address risk factors for lifestyle-related causes of death, as well as monitoring for and care of diseases associated with old age will be necessary if the full benefit of ART in decreasing mortality is to continue in the second decade of ART.

Related Stories

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

ThanderMAX
not rated yet Apr 28, 2010
Until we find a definitive cure , its indeed a good news.

We need to encourage HIV victims to live a more cheerful life instead of living with anxiety and fear of death.
ThanderMAX
not rated yet Apr 28, 2010
HIV now a days is more like Diabetes, incurable currently but people can live with proper medication and diet.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.